Skip to main content

Table 3 Meta-analyses of miR-140 expression classified by clinicopathological parameters

From: Prognostic and clinicopathological importance of microRNA-140 expression in cancer patients: a meta-analysis

Study covariates Studies (patients) OR (95% CI) I2 (%) Ph Z P Model
Gender (male/female) 7 (770) 1.068 (0.761-1.499) 30.0 0.199 0.38 0.703 Fixed
Age (< 60/≥ 60) 3 (257) 0.859 (0.500-1.475) 0.0 0.519 0.55 0.582 Fixed
Tumor size (≤ 5/> 5 cm) 3 (257) 1.152 (0.352-3.773) 79.0 0.008 0.23 0.815 Random
TNM stage (1-2/3-4) 6 (614) 0.420 (0.299-0.590) 43.4 0.113 5.00 < 0.001 Fixed
LN metastasis (absence/presence) 6 (568) 0.341 (0.144-0.807) 78.9 < 0.001 2.45 0.014 Random
Histologic grade (well+ moderately differentiated/ poorly differentiated) 4 (389) 0.410 (0.261-0.643) 0.0 0.552 3.88 < 0.001 Fixed
  1. LN lymph node, OR odds ratio, CI confidence intervals, Ph P value for heterogeneity based on Q test, P P value for statistical significance based on Z test